UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

The New England journal of medicine, 2017-02, Vol.376 (5), p.417-428

2017

Volltextzugriff (PDF)

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

European urology, 2012-04, Vol.61 (4), p.705-711

2012

Volltextzugriff (PDF)

Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4055-4061

2009

Volltextzugriff (PDF)

Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233

International journal of radiation oncology, biology, physics, 2016-01, Vol.94 (1), p.67-74

2016

Volltextzugriff (PDF)

Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer

International journal of radiation oncology, biology, physics, 2013-06, Vol.86 (2), p.311-316

2013

Volltextzugriff (PDF)

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience

European urology, 2017-06, Vol.71 (6), p.952-960

2017

Volltextzugriff (PDF)

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233

Journal of clinical oncology, 2014-12, Vol.32 (34), p.3801-3809

2014

Volltextzugriff (PDF)

Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases

Human pathology, 2013-05, Vol.44 (5), p.860-866

2013

Volltextzugriff (PDF)

Bladder preservation: optimizing radiotherapy and integrated treatment strategies

BJU international, 2008-11, Vol.102 (9b), p.1345-1353

2008

Volltextzugriff (PDF)

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

European urology, 2017-07, Vol.72 (1), p.54-60

2017

Volltextzugriff (PDF)

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer

The Journal of urology, 2018-02, Vol.199 (2), p.407-415

2018

Volltextzugriff (PDF)

Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy

Urology (Ridgewood, N.J.), 2009-04, Vol.73 (4), p.833-837

2009

Volltextzugriff (PDF)

Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer

The Journal of urology, 2012-02, Vol.187 (2), p.463-468

2012

Volltextzugriff (PDF)

PD36-12 COMPARING COMPLICATIONS AND SURVIVAL OF PRIMARY CYSTECTOMY VS. SALAVAGE CYSTECTOMY AFTER TRIMODAL THERAPY

The Journal of urology, 2017-04, Vol.197 (4), p.e673-e673

2017

Volltextzugriff (PDF)

MP26-12 INCIDENCE AND MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCES AFTER COMPLETE RESPONSE TO COMBINED-MODALITY ORGAN-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

The Journal of urology, 2015-04, Vol.193 (4), p.e298-e298

2015

Volltextzugriff (PDF)

Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder

Urologia internationalis, 2015-01, Vol.94 (4), p.401-405

2015

Volltextzugriff (PDF)

The Initial Results in Muscle‐Invading Bladder Cancer of RTOG 95‐06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5‐Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response

The oncologist (Dayton, Ohio), 2000-12, Vol.5 (6), p.471-476

2000

Volltextzugriff (PDF)

Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer

Current urology reports, 2013-04, Vol.14 (2), p.109-115

2013

Volltextzugriff (PDF)

The results of concurrent chemo‐radiotherapy for recurrence after treatment with bacillus Calmette‐Guérin for non‐muscle‐invasive bladder cancer: is immediate cystectomy always necessary?

BJU international, 2009-07, Vol.104 (2), p.179-183

2009

Volltextzugriff (PDF)

Surgery Selective bladder-preserving therapy for muscle-invasive cancer

Nature reviews. Clinical oncology, 2009-04, Vol.6 (4), p.193-194

2009

Volltextzugriff (PDF)

Selective bladder-preserving therapy for muscle-invasive cancer

Nature reviews. Clinical oncology, 2009-04, Vol.6 (4), p.193-194

2009

Volltextzugriff (PDF)

Selective Bladder Preservation by Combination Treatment of Invasive Bladder Cancer

The New England journal of medicine, 1993-11, Vol.329 (19), p.1377-1382

1993

Volltextzugriff (PDF)

Bladder-sparing approaches to invasive disease

World journal of urology, 2006-11, Vol.24 (5), p.517-529

2006

Volltextzugriff (PDF)

Case 39-2003: A 33-Year-Old Woman with Gross Hematuria

The New England journal of medicine, 2003-12, Vol.349 (25), p.2442-2447

2003

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(79)
Tagungsberichte
(1)

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

Humans
(52)
Life Sciences & Biomedicine
(49)
Science & Technology
(49)
Urology & Nephrology
(31)
Male
(29)
Middle Aged
(29)
Aged
(27)
Urinary Bladder Neoplasms - Pathology
(27)
Female
(25)
Urinary Bladder Neoplasms - Therapy
(25)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Neoplasm Invasiveness
(23)
Combined Modality Therapy
(20)
Adult
(19)
Cystectomy
(17)
Urinary Bladder Neoplasms - Mortality
(17)
Nephrology. Urinary Tract Diseases
(16)
Oncology
(16)
Treatment Outcome
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06

Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233

Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233

Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01

Bladder preservation: optimizing radiotherapy and integrated treatment strategies

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer

Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy

Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer

PD36-12 COMPARING COMPLICATIONS AND SURVIVAL OF PRIMARY CYSTECTOMY VS. SALAVAGE CYSTECTOMY AFTER TRIMODAL THERAPY

MP26-12 INCIDENCE AND MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCES AFTER COMPLETE RESPONSE TO COMBINED-MODALITY ORGAN-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder

The Initial Results in Muscle‐Invading Bladder Cancer of RTOG 95‐06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5‐Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response

Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer

The results of concurrent chemo‐radiotherapy for recurrence after treatment with bacillus Calmette‐Guérin for non‐muscle‐invasive bladder cancer: is immediate cystectomy always necessary?

Surgery Selective bladder-preserving therapy for muscle-invasive cancer

Selective bladder-preserving therapy for muscle-invasive cancer

Selective Bladder Preservation by Combination Treatment of Invasive Bladder Cancer

Bladder-sparing approaches to invasive disease

Case 39-2003: A 33-Year-Old Woman with Gross Hematuria

Suchergebnisse filtern